PharmiWeb.com - Global Pharma News & Resources
15-Feb-2019

Cerebral Malaria Therapeutics Market 2019: Detailed Analysis of Production Demand and Consumption Growth Rate by 2028

Cerebral malaria is a type of malaria with high severity, which is caused from infection spread by mosquito. Cerebral malaria is multi-organ disease, has high mortality rate, and can cause various neurological complications in human beings. Common symptoms include chills, fever, repeated seizures, nystagmus, etc. Cerebral malaria is a form of severe malaria which arises from infection with the protozoan parasite Plasmodium falciparum. Cerebral malaria has high mortality rate and can cause various complications in the neurology. Cerebral malaria can cause severe central nervous system (CNS) manifestations such as impaired consciousness, delirium, abnormal neurological signs, etc. Patients with cerebral malaria mostly manifest neurological symptoms such as nystagmus, opisthotonus, etc.

To get more insights, visit: https://marketresearch.biz/report/cerebral-malaria-therapeutics-market/

In terms of drug class, the market has been categorized into anti-malarial, tetracycline antibiotics, analgesics & pain relievers, anti-rheumatics, and anti-arrhythmics. Among all the drug class segments, anti-malarial segment is expected to contribute high revenue share to the global market. The tetracycline antibodies segment is estimated to witness high growth owing to its offerings of effective treatment/killing of parasites that cause malaria. On the basis of distribution channel, the market has been segmented into drug store, hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment holds major share in the global market due to easy access for patients to get diagnosed and buy medicines. Online pharmacies are expected to witness high growth owing to rising preference for online medicines purchase by patients, as it is time saving and patients can avail medicines at discounted prices on online stores.

On the basis of region, the global cerebral malaria therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America market is expected to lead in terms of revenue. Europe holds second position, followed by Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is expected to witness high CAGR owing to constant increase in number of malaria patients, and rising standards of healthcare sector.

Get Free Sample Copy Of This Research @ https://marketresearch.biz/report/cerebral-malaria-therapeutics-market/request-sample/

Major players operating in the cerebral malaria therapeutics market include Cipla, Inc., Que Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Guilin Pharmaceutical (Shanghai) Co., Ltd., Ipca Laboratories Ltd., Novartis AG, Ajanta Pharma, Sanofi, Mylan Labs, and Astra Zeneca plc

Global Market Research Report Targets The Following People:

* Product manager, industry executives, chief regulative officers of the industries.
* Market Researchers, analyst, research executives, and laboratory experts.
* Universities, students, professors, interns, and different other academic institutes related to the market.
* Writer, editors, reporters, journalists and webmasters connected to the market.
* Private organizations, government organizations, project managers associates with industry.
* Present or upcoming market players.

Editor Details

Last Updated: 15-Feb-2019